参考文献

［1］　陈灏珠.实用心脏病学［M］.5版.上海：上海科学技术出版社，2016：695-708.

［2］　Schwinger RHG.Pathophysiology of heart failure［J］.Cardiovasc Diagn Ther，2021，11：263-276.

［3］　Panjrath G，Ahmed A.Diagnosis and management of heart failure in older adults［J］.Heart Fail Clin，2017，13：427-444.

［4］　Marra AM，Benjamin N，Cittadini A.When pulmonary hypertension complicates heart failure［J］.Heart Fail Clin，2020，16：53-60.

［5］　Nagueh SF.Left ventricular diastolic function：Understanding pathophysiology，diagnosis，and prognosis with echocardiography［J］.JACC Cardiovasc Imaging，2020，13：228-244.(https://www.daowen.com)

［6］　Tanaka H.Utility of strain imaging in conjunction with heart failure stage classification for heart failure patient management［J］.J Echocardiogr，2019，17：17-24.

［7］　Chow SL，Maisel AS，Anand I，et al.Role of biomarkers for the prevention，assessment，and management of heart failure：A scientific statement from the American Heart Association［J］.Circulation，2017，135：e1054-e1091.

［8］　Correale M，Monaco I，Brunetti ND，et al.Redefining biomarkers in heart failure［J］.Heart Fail Rev，2018，23：237-253.

［9］　Ponikowski P，Voors AA，Anker SD，et al.2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure：The task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology（ESC）.Developed with the special contribution of the Heart Failure Association（HFA）of the ESC［J］.Eur J Heart Fail，2016，18：891-975.